About US
Contact us
-
Lipitor going generic, Pfizer making deals to keep consumersThe popular cholesterol-lowering drug Lipitor goes off-patent today. Manufacturer Pfizer planned ahead, making agreements with some insurers to keep covering the drug. The New York Times: Facing Ge2011/12/2
-
Taking sleep medication or drinking alcohol does not benefit people with insomniaReaching for that sleeping pill or drinking alcohol may not be the most effective way for people with insomnia to get better sleep at night in the long run, suggests a new study by Ryerson University2011/12/2
-
SFDA Commissioner Shao Mingli meets delegation led by Former U.S. Assistant to the President for National Security AffairsOn November 30, 2011, Shao Mingli, Commissioner of the State Food and Drug Administration (SFDA) met with the Advanced Medical Technology Association of America delegation headed by Samuel Berger, For2011/12/2
-
Pfizer backs its highest grosser LipitorBy Dr Ananya Mandal, MD Pfizer’s Lipitor, a blood cholesterol lowering drug, is a popular one the among general population. However now that a generic competition for the drug has arrived in the ma2011/12/1
-
Associated Press examines Chinese vaccine makers' entry into international market"China's vaccine makers are gearing up over the next few years to push exports in a move that should lower costs of lifesaving immunizations for the world's poor and provide major new competition for2011/12/1
-
SFDA Commissioner Shao Mingli attends the signing ceremony of Cooperation Agreement for Establishing Hong Kong's Chinese Crude Drugs Standards between NIFDC and Hong Kong Department of HealthOn the afternoon of November 22, 2011, Li Yunlong, Director of National Institutes for Food and Drug Control (NIFDC), and Dr. P.Y. LAM, Director of Health of the Government of the Hong Kong Special Ad2011/12/1
-
Guiding Opinions on Accelerating the Construction of the Monitoring System of Cosmetic Adverse Reactions issuedIn order to speed up the construction of the monitoring system of cosmetic adverse reactions, strengthen the monitoring and evaluation of cosmetic adverse reactions and safeguard the consumer’s health2011/12/1
-
SFDA Commissioner Shao Mingli met Swedish Minister for Children and the Elderly and signed bilateral MOUOn the afternoon of November 23, 2011, Shao Mingli, Commissioner of the State Food and Drug Administration (SFDA), met with the visiting Ms. Maria Larsson, Minister for Children and the Elderly, Minis2011/12/1
-
AZ bolsters VC arm with $100 million, buys into Australian firmAstraZeneca has committed an additional $100 million to its venture capital arm and announced an investment in Australian life sciences start-up NeuProtect. The Anglo-Swedish drugmaker's MedImmune2011/11/30
-
EU OK for Komboglyze, expanded use for OnglyzaAstraZeneca and Bristol-Myers Squibb are celebrating after regulators in Europe gave approvals for two of their diabetes drugs. First up, European Commission has granted marketing authorisation for2011/11/30